Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Homology Medicines, Inc. | Director | Stock Option (Right to Buy) | 12.8K | $171K | $13.42 | Mar 25, 2024 | Direct |
Vigil Neuroscience, Inc. | Director | Stock Option Award (Right to Buy) | 18.1K | $138K | $7.62 | Jun 5, 2024 | Direct |
Alaunos Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 100K | Jun 6, 2023 | Direct | ||
Cullinan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25.7K | Aug 8, 2024 | Direct | ||
Entrada Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 13, 2024 | Direct | ||
Vigil Neuroscience, Inc. | Director | Stock Option Grant (Right to Buy) | 13.9K | Jun 7, 2023 | Direct |